2020年拉丁美洲和加勒比地区视力丧失患病率:规模和时间趋势

IF 1.2 4区 医学 Q3 OPHTHALMOLOGY
Vision Loss Expert Group Of The Global Burden Of Disease Study, The Gbd Blindness And Vision Impairment Collaborators
{"title":"2020年拉丁美洲和加勒比地区视力丧失患病率:规模和时间趋势","authors":"Vision Loss Expert Group Of The Global Burden Of Disease Study, The Gbd Blindness And Vision Impairment Collaborators","doi":"10.1080/09286586.2025.2464168","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To estimate the prevalence of vision loss for 2020 in Latin America and the Caribbean (LAC) and analyse evolving trends since 1990.</p><p><strong>Methods: </strong>A meta-analysis using hierarchical models of 37 sources of 33 cross-sectional, population-representative studies from LAC from 1998 to 2018 was undertaken to determine the prevalence of blindness, moderate and severe vision impairment (MSVI), and mild vision impairment (mild VI), with 95% uncertainty intervals (UIs).</p><p><strong>Results: </strong>In 2020, the age-standardised prevalence rates of blindness, MSVI, moderate vision impairment (VI), severe VI, and mild VI, were 0.51% (95% UI 0.44%-0.57%), 3.73% (95% UI 3.38%-4.08%), 3.35% (95% UI 3.00%-3.69%), 0.38% (95% UI 0.34%-0.43%), and 3.19% (95% UI 2.87%-3.53%), respectively. In 1990, there were 15.81 million people with blindness and MSVI in LAC, contributing to 8.66% of the global caseload. In 2020, there were 30.42 million people, including 3.82 million (95% UI 3.14-4.55 million) with blindness and 26.6 million (95% UI 23.08-30.3 million) with MSVI, who contributed to 8.99% of the global caseload.</p><p><strong>Conclusion: </strong>The contribution of vision loss to the overall global burden from LAC has increased over the last 3 decades, and the numbers of people affected with blindness and VI reported throughout the region have also steadily increased. There needs to be greater attention to providing universal eye health coverage across the region.</p>","PeriodicalId":19607,"journal":{"name":"Ophthalmic epidemiology","volume":" ","pages":"1-7"},"PeriodicalIF":1.2000,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prevalence of Vision Loss in Latin America and the Caribbean in 2020: Magnitude and Temporal Trends.\",\"authors\":\"Vision Loss Expert Group Of The Global Burden Of Disease Study, The Gbd Blindness And Vision Impairment Collaborators\",\"doi\":\"10.1080/09286586.2025.2464168\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To estimate the prevalence of vision loss for 2020 in Latin America and the Caribbean (LAC) and analyse evolving trends since 1990.</p><p><strong>Methods: </strong>A meta-analysis using hierarchical models of 37 sources of 33 cross-sectional, population-representative studies from LAC from 1998 to 2018 was undertaken to determine the prevalence of blindness, moderate and severe vision impairment (MSVI), and mild vision impairment (mild VI), with 95% uncertainty intervals (UIs).</p><p><strong>Results: </strong>In 2020, the age-standardised prevalence rates of blindness, MSVI, moderate vision impairment (VI), severe VI, and mild VI, were 0.51% (95% UI 0.44%-0.57%), 3.73% (95% UI 3.38%-4.08%), 3.35% (95% UI 3.00%-3.69%), 0.38% (95% UI 0.34%-0.43%), and 3.19% (95% UI 2.87%-3.53%), respectively. In 1990, there were 15.81 million people with blindness and MSVI in LAC, contributing to 8.66% of the global caseload. In 2020, there were 30.42 million people, including 3.82 million (95% UI 3.14-4.55 million) with blindness and 26.6 million (95% UI 23.08-30.3 million) with MSVI, who contributed to 8.99% of the global caseload.</p><p><strong>Conclusion: </strong>The contribution of vision loss to the overall global burden from LAC has increased over the last 3 decades, and the numbers of people affected with blindness and VI reported throughout the region have also steadily increased. There needs to be greater attention to providing universal eye health coverage across the region.</p>\",\"PeriodicalId\":19607,\"journal\":{\"name\":\"Ophthalmic epidemiology\",\"volume\":\" \",\"pages\":\"1-7\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2025-05-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ophthalmic epidemiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/09286586.2025.2464168\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmic epidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09286586.2025.2464168","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:估计2020年拉丁美洲和加勒比地区(LAC)视力丧失的患病率,并分析1990年以来的发展趋势。方法:采用分层模型对1998年至2018年LAC地区33项具有人口代表性的横断面研究的37个来源进行meta分析,以确定失明、中度和重度视力障碍(MSVI)和轻度视力障碍(轻度VI)的患病率,不确定性区间为95% (ui)。结果:2020年,我市失明、重度svi、中度VI、重度VI、轻度VI的年龄标准化患病率分别为0.51% (95% UI 0.44% ~ 0.57%)、3.73% (95% UI 3.38% ~ 4.08%)、3.35% (95% UI 3.00% ~ 3.69%)、0.38% (95% UI 0.34% ~ 0.43%)、3.19% (95% UI 2.87% ~ 3.53%)。1990年,拉丁美洲和加勒比地区有1581万失明和MSVI患者,占全球病例数的8.66%。2020年,全球有3042万人,其中失明382万人(95% UI为314 - 455万)和重度svi 2660万人(95% UI为2308 - 3030万),占全球病例量的8.99%。结论:在过去30年里,拉美和加勒比地区视力丧失对全球总体负担的贡献有所增加,整个地区报告的失明和VI患者人数也在稳步增加。需要更加重视在整个区域提供普遍的眼科保健覆盖。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Prevalence of Vision Loss in Latin America and the Caribbean in 2020: Magnitude and Temporal Trends.

Purpose: To estimate the prevalence of vision loss for 2020 in Latin America and the Caribbean (LAC) and analyse evolving trends since 1990.

Methods: A meta-analysis using hierarchical models of 37 sources of 33 cross-sectional, population-representative studies from LAC from 1998 to 2018 was undertaken to determine the prevalence of blindness, moderate and severe vision impairment (MSVI), and mild vision impairment (mild VI), with 95% uncertainty intervals (UIs).

Results: In 2020, the age-standardised prevalence rates of blindness, MSVI, moderate vision impairment (VI), severe VI, and mild VI, were 0.51% (95% UI 0.44%-0.57%), 3.73% (95% UI 3.38%-4.08%), 3.35% (95% UI 3.00%-3.69%), 0.38% (95% UI 0.34%-0.43%), and 3.19% (95% UI 2.87%-3.53%), respectively. In 1990, there were 15.81 million people with blindness and MSVI in LAC, contributing to 8.66% of the global caseload. In 2020, there were 30.42 million people, including 3.82 million (95% UI 3.14-4.55 million) with blindness and 26.6 million (95% UI 23.08-30.3 million) with MSVI, who contributed to 8.99% of the global caseload.

Conclusion: The contribution of vision loss to the overall global burden from LAC has increased over the last 3 decades, and the numbers of people affected with blindness and VI reported throughout the region have also steadily increased. There needs to be greater attention to providing universal eye health coverage across the region.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Ophthalmic epidemiology
Ophthalmic epidemiology 医学-眼科学
CiteScore
3.70
自引率
5.60%
发文量
61
审稿时长
6-12 weeks
期刊介绍: Ophthalmic Epidemiology is dedicated to the publication of original research into eye and vision health in the fields of epidemiology, public health and the prevention of blindness. Ophthalmic Epidemiology publishes editorials, original research reports, systematic reviews and meta-analysis articles, brief communications and letters to the editor on all subjects related to ophthalmic epidemiology. A broad range of topics is suitable, such as: evaluating the risk of ocular diseases, general and specific study designs, screening program implementation and evaluation, eye health care access, delivery and outcomes, therapeutic efficacy or effectiveness, disease prognosis and quality of life, cost-benefit analysis, biostatistical theory and risk factor analysis. We are looking to expand our engagement with reports of international interest, including those regarding problems affecting developing countries, although reports from all over the world potentially are suitable. Clinical case reports, small case series (not enough for a cohort analysis) articles and animal research reports are not appropriate for this journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信